Imperial College London

Dr Robin Carhart-Harris

Faculty of MedicineDepartment of Brain Sciences

Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 7992r.carhart-harris

 
 
//

Assistant

 

Miss Bruna Cunha +44 (0)20 7594 7992

 
//

Location

 

Burlington DanesHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Roseman:10.1177/0269881119855974,
author = {Roseman, L and Haijen, E and Idialu-Ikato, K and Kaelen, M and Watts, R and Carhart-Harris, R},
doi = {10.1177/0269881119855974},
journal = {Journal of Psychopharmacology},
pages = {026988111985597--026988111985597},
title = {Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory},
url = {http://dx.doi.org/10.1177/0269881119855974},
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - <jats:sec><jats:title>Background:</jats:title><jats:p> Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (45). </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being ( r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores
AU - Roseman,L
AU - Haijen,E
AU - Idialu-Ikato,K
AU - Kaelen,M
AU - Watts,R
AU - Carhart-Harris,R
DO - 10.1177/0269881119855974
EP - 026988111985597
SN - 0269-8811
SP - 026988111985597
TI - Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
T2 - Journal of Psychopharmacology
UR - http://dx.doi.org/10.1177/0269881119855974
ER -